Insurers and sponsors tasked with funding new drugs or limiting their usage.

Find out how to enhance client experience and drive referrals your way.

Second highest quarter-over-quarter growth rate reported since 2016.

Approximately 16,000 accounts to be transferred upon transaction’s completion.

This marks its second acquisition in Ontario since the start of the year.

Pricing and higher cedent retentions allow reinsurers to shrug off losses.

Highest sales ever recorded in the Canadian market since the LIMRA survey was established.